CECarsten Eriksen

Carsten Eriksen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carsten Eriksen has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Author Correction: Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization

    by Pernille Neve Myers, Rasmus Kaae Dehli, Axel Mie, Janne Marie Moll, Henrik Munch Roager, Carsten Eriksen, Martin Frederik Laursen, Ellen Magdalena Staudinger, Ioanna Chatzigiannidou, Pi Lærke Johansen, et al.

  • Open Access

    Gut microbiota composition outperforms chronological age in predicting systemic inflammation and incident disease risk

    by Carsten Eriksen, Ioanna Chatzigiannidou, Rasmus Kaae Dehli, Pi Lærke Johansen, Thomas Meinertz Dantoft, Oluf Pedersen, Torben Hansen, Allan Linneberg, Tine Jess, Kristine Højgaard Allin, et al.

    Low-grade systemic inflammation increases with age and accompanies many age-associated lifestyle-related diseases, yet substantial inter-individual variability exists beyond chronological age. Given the gut microbiota’s role in immune regulation, we analyzed paired fecal microbiota profiles, 30 plasma cytokines, and 19 biochemical and physiological measures in 1,199 adults (aged 20-72) from the population-based DanFunD cohort to assess the relative associations of microbiota composition and age with systemic inflammation and subsequent disease risk. Here we show that despite an association between age and 40% of inflammatory cytokines and most physiological variables, gut microbiota composition explained more variance than age for 97% of cytokines and 84% of physiological variables. Individuals with the Bacteroides 2 enterotype exhibited elevated pro-inflammatory cytokines and adverse metabolic profiles already in early adulthood, displaying an inflammaging-like phenotype up to 37 years earlier than other enterotypes. This enterotype was associated with increased risk of future incident disease across multiple organ systems (hazard ratio 1.21), with mediation analyses suggesting that inflammatory cytokines accounted for part of this association. Conversely, a high-diversity enterotype was linked to lower inflammation and reduced disease risk. These findings position gut microbiota composition as a stronger correlate of systemic inflammatory tone than chronological age and a potentially modifiable determinant of inflammation-related disease trajectories across adulthood.


  • Open Access

    Dual human milk oligosaccharide-fibre utilisation is a selection cue for the weaning gut microbiome

    by Yunjeong So, Michael Jakob Pichler, Susanne Søndergaard Kappel, Chunsheng Jin, Carsten Eriksen, Ioanna Chatzigiannidou, Maria Haugaard Bohl Andersen, Vasileios Tsiamis, Marie Vestergaard Lukassen, Lea Eschen Skytthe, et al.

    Gut microbiome (GM) maturation in early life follows organised taxonomic successions, yet how the weaning diet impacts these trajectories remains underexplored. Here, we collected faecal samples at pre-, early and late weaning from seven mother-infant dyads forming the Milkome cohort, designed to evaluate the contribution of human milk oligosaccharides (HMOs) to GM maturation during weaning (NCT07026526). Surprisingly, all preweaning infant faecal consortia grew on multiple dietary fibres, consistent with the prevalence of fibre-degradation genes in their metagenomes. Utilisation of both HMOs and dietary fibres was discovered as a metabolic hallmark of the weaning GM, as supported by metagenomics and the growth of faecal consortia on HMOs, following their enrichment on fibres. The growth of a defined consortium on weaning-mimic substrates, further showed that distinct Clostridia simultaneously deploy HMO and fibre utilisation pathways, which confers competitive growth against HMO- or fibre-utilising bifidobacteria. Metagenomics, culturomics and HMO-utilisation profiles of 137 maternal isolates were concordant with retention of the HMO-utilisation capacity by the adult GM. Our findings highlight dual HMO-fibre utilisation as an unrecognised selection cue of core adult GM species during weaning, which outlines a plausible mechanism of GM maturation in early life and extends the importance of HMOs to the weaning transition.

  • Top Cited Papers

    Early-life colonization by aromatic-lactate-producing bifidobacteria lowers the risk of allergic sensitization

    by Pernille Neve Myers, Rasmus Kaae Dehli, Axel Mie, Janne Marie Moll, Henrik Munch Roager, Carsten Eriksen, Martin Frederik Laursen, Ellen Magdalena Staudinger, Ioanna Chatzigiannidou, Pi Lærke Johansen, et al.

    Early-life microbial exposures shape immune development and allergy risk. Food allergen sensitization, reflected by the presence of food allergen-specific immunoglobulin E (IgE), is an early indication of impaired immune tolerance. Here we show that early-life transmission of aromatic lactate-producing bifidobacteria strains in 147 children followed from birth to 5 years of age, facilitated by vaginal delivery, exposure to older siblings and exclusive breastfeeding for the first 2 months, led to increased levels of aromatic lactates in the infant gut. This microbiota–metabolite signature was inversely associated with the development of food allergen-specific IgE until 5 years and atopic dermatitis at 2 years. The observed effect was mediated by 4-hydroxy-phenyllactate, which inhibited IgE, but not IgG, production in ex vivo human immune cell cultures. Together, these findings define an early-life microbiota–metabolite–immune axis linking microbial transmission and feeding practices with reduced allergic sensitization.


  • Open Access

    Temporal dynamics and microbial interactions shaping the gut resistome in early infancy

    by Ioanna Chatzigiannidou, Pi L. Johansen, Rasmus K. Dehli, Janne Marie Moll, Carsten Eriksen, Pernille N. Myers, Henrik M. Roager, Lili Yang, Jakob Stokholm, Søren J. Sørensen, et al.

    Despite the critical role of the gut resistome in spreading of antimicrobial resistance (AMR), strategies to reduce the abundance of antibiotic resistance genes (ARGs) during microbiota development in infancy remain underexplored. Using longitudinal quantitative metagenomic data, we here show that ARGs are present in the gut microbiota from the first week of life, with a peak in absolute ARG abundance and richness at 6 months. Delivery mode significantly affects early ARG dynamics, and vaginally delivered infants exhibit higher ARG abundance due to maternal transmission of Escherichia coli strains harbouring extensive resistance repertoires. The abundance of E. coli and other ARG-rich taxa inversely correlates with aromatic lactic acid-producing bifidobacteria, and aromatic lactic acids strongly inhibit the in vitro growth of E. coli and other opportunistic ARG-rich taxa. Our results highlight temporal and critical microbial interactions shaping the gut resistome in early infancy, pointing to potential interventions to curb AMR during this vulnerable developmental window by promoting colonization of aromatic lactic acid-producing bifidobacteria.


  • Open Access

    Dual human milk oligosaccharide-fibre utilisation drives gut microbiome selection during weaning

    by Yunjeong So, Michael Jakob Pichler, Susanne Søndergaard Kappel, Chunsheng Jin, Carsten Eriksen, Ioanna Chatzigiannidou, Susann Teneberg, Karsten Kristiansen, Susanne Brix, Lise Aunsholt, et al.

    Gut microbiome (GM) maturation in early life follows organised taxonomic successions. How weaning impacts these trajectories remains underexplored. Here, we sampled faeces from seven mother-infant dyads at pre-, early and late weaning. Enrichment cultures (n=306) and metagenomic (n=108) analyses revealed an unexpected prevalence of fibre degradation genes and the growth of the pre-weaning infant GM on common dietary fibres. Utilisation of both human milk oligosaccharides (HMOs) and dietary fibres was revealed as a metabolic hallmark of the weaning GM. We showed that HMO-utilisation is retained beyond weaning, by analyses of maternal GM and HMO utilisation in 137 maternal isolates. Our findings highlight dual HMO-dietary fibre utilisation as a hitherto unrecognised driver that potentially orchestrates the selection of distinct adult GM species during weaning. This work outlines a plausible mechanism underlying the organised GM maturation in early life and highlights a previously overlooked role of HMOs during the weaning transition.

  • Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn’s disease

    by Carsten Eriksen, Niels Banhos Danneskiold-Samsøe, Janne Marie Moll, Pernille Neve Myers, Pi W Bondegaard, Simone Vejrum, Tine Brodka Hansen, Lisbeth Buus Rosholm, Philipp Rausch, Kristine Højgaard Allin, et al.

    Objective: Patients with Crohn’s disease (CD) exhibit great heterogeneity in disease presentation and treatment responses, where distinct gut bacteria and immune interactions may play part in the yet unresolved disease aetiology. Given the role of antibodies in the barrier defence against microbes, we hypothesised that gut bacterial antibody-coating patterns may influence underlying disease-mediated processes.Design: Absolute and relative single and multicoating of gut bacteria with IgA, IgG1, IgG2, IgG3 and IgG4 in patients with CD and healthy controls were characterised and compared with disease activity. IgG2-coated and non-coated taxa from patients with severe CD were identified, profiled for pathogenic characteristics and monitored for enrichment during active disease across cohorts.Results: Patients with severe CD exhibited higher gut bacterial IgG2-coating. Supervised clustering identified 25 bacteria to be enriched in CD patients with high IgG2-coating. Sorting, sequencing andin silico-based assessments of the virulent potential of IgG2-coated and bulk stool bacteria were performed to evaluate the nature and pathogenicity of IgG2-coated and non-coated bacteria. The analyses demonstrated IgG2-coating of both known pathogenic and non-pathogenic bacteria that co-occurred with two non-coated pathobionts,CampylobacterandMannheimia. The two non-coated pathobionts exhibited low prevalence, rarely coincided and were strongly enriched during disease flares in patients with CD across independent and geographically distant cohorts.Conclusion: Distinct gut bacterial IgG2-coating was demonstrated in patients with severe CD and during disease flares. Co-occurrence of non-coated pathobionts with IgG2-coated bacteria points to an uncontrolled inflammatory condition in severe CD mediated via escape from antibody coating by two gut pathobionts.


  • Open Access

    Gut microbiota signatures in inflammatory bowel disease

    by Marie Vibeke Vestergaard, Kristine H. Allin, Carsten Eriksen, Oliwia Zakerska‐Banaszak, Ramesh P. Arasaradnam, Mohammad T. Alam, Karsten Kristiansen, Susanne Brix, Tine Jess

    Background: Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), affect millions of people worldwide with increasing incidence.Objectives: Several studies have shown a link between gut microbiota composition and IBD, but results are often limited by small sample sizes. We aimed to re‐analyze publicly available fecal microbiota data from IBD patients.Methods: We extracted original fecal 16S rRNA amplicon sequencing data from 45 cohorts of IBD patients and healthy individuals using the BioProject database at the National Center for Biotechnology Information. Unlike previous meta‐analyses, we merged all study cohorts into a single dataset, including sex, age, geography, and disease information, based on which microbiota signatures were analyzed, while accounting for varying technical platforms.Results: Among 2518 individuals in the combined dataset, we discovered a hitherto unseen number of genera associated with IBD. A total of 77 genera associated with CD, of which 38 were novel associations, and a total of 64 genera associated with UC, of which 28 represented novel associations. Signatures were robust across different technical platforms and geographic locations. Reduced alpha diversity in IBD compared to healthy individuals, in CD compared to UC, and altered microbiota composition (beta diversity) in UC and especially in CD as compared to healthy individuals were found.Conclusions: Combining original microbiota data from 45 cohorts, we identified a hitherto unseen large number of genera associated with IBD. Identification of microbiota features robustly associated with CD and UC may pave the way for the identification of new treatment targets.


  • Open Access

    Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn’s disease

    by Carsten Eriksen, Niels B. Danneskiold-Samsøe, Janne M. Moll, Pernille N. Myers, Pi W. Bondegaard, Simone Vejrum, Tine B. Hansen, Lisbeth B. Rosholm, Philipp Rausch, Kristine H. Allin, et al.

    Patients with Crohn’s disease (CD) exhibit great heterogeneity in disease presentation and treatment responses, where distinct gut microbiota-host interplays may play part in the yet unresolved disease etiology. We here characterized absolute and relative single and multi-coating of gut bacteria with immunoglobulin (Ig)A, IgG1, IgG2, IgG3 and IgG4 in CD patients and healthy controls. Patients with severe disease exhibited distinctly higher gut bacterial IgG2-coating. IgG2-coated bacteria included both known pathogenic and non-pathogenic bacteria that co-existed in communities with two non-coated gut pathobionts Campylobacter and Mannheimia . These latter two exhibited low prevalence, rarely coincided, and were strongly enriched during disease flares in CD patients across independent and geographically distant cohorts. Since antibody-coating of gut pathobionts diminishes epithelial invasion and inflammatory processes, escape from coating by specific gut pathobionts may be a mechanism related to disease flares in the subgroup of CD patients with severe disease.


  • Division of Labor during Biofilm Matrix Production

    by Anna Dragoš, Heiko Kiesewalter, Marivic Martin, Chih-Yu Hsu, Raimo Hartmann, Tobias Wechsler, Carsten Eriksen, Susanne Brix, Knut Drescher, Nicola Stanley-Wall, et al.